Literature DB >> 24353855

Arachnoiditis following caudal epidural injections for the lumbo-sacral radicular pain.

Shashi Kumar Nanjayan1, Girish Nanjunda Swamy1, Sachin Yallappa1, Rajendra Bommireddy1.   

Abstract

Caudal epidural steroid injection is a very common intervention in treatment of low back pain and sciatica symptoms. Although extensively used, it is not devoid of complications. A few reports of chemical and infective arachnoiditis exist following lumbar epidural anaesthesia, but none following a caudal epidural steroid injection.We report a case of arachnoiditis following caudal epidural steroid injections for lumbar radiculopathy. The patient presented with contralateral sciatica, worsening low back pain and urinary retention few days following the injection, followed by worsening motor functions in L4/L5/S1 myotomes with resultant dense foot drop. Gadolinium-enhanced magnetic resonance imaging suggested infective arachnoiditis with diffuse enhancement and clumping of the nerve roots within the lumbar and sacral thecal sac. As the number of injections in the management of back pain and lumbo-sacral radicular pain is increasing annually, it is imperative to have a thorough understanding of this potentially dangerous complication and educate the patients appropriately.

Entities:  

Keywords:  Arachnoiditis; Caudal; Epidural; Low back pain; Sciatica

Year:  2013        PMID: 24353855      PMCID: PMC3863664          DOI: 10.4184/asj.2013.7.4.355

Source DB:  PubMed          Journal:  Asian Spine J        ISSN: 1976-1902


  8 in total

1.  From the Centers for Disease Control and Prevention. Exophiala infection from contaminated injectable steroids prepared by a compounding pharmacy--United States, July-November 2002.

Authors: 
Journal:  JAMA       Date:  2003-01-15       Impact factor: 56.272

2.  Complications of fluoroscopically guided caudal epidural injections.

Authors:  K P Botwin; R D Gruber; C G Bouchlas; F M Torres-Ramos; A Hanna; J Rittenberg; S A Thomas
Journal:  Am J Phys Med Rehabil       Date:  2001-06       Impact factor: 2.159

3.  Caudal epidural steroid injections.

Authors:  B A Ogoke
Journal:  Pain Physician       Date:  2000-07       Impact factor: 4.965

Review 4.  Epidural abscess and meningitis after epidural corticosteroid injection.

Authors:  W Michael Hooten; Michelle O Kinney; Marc A Huntoon
Journal:  Mayo Clin Proc       Date:  2004-05       Impact factor: 7.616

Review 5.  Lumbar and caudal epidural corticosteroid injections.

Authors:  K C Spaccarelli
Journal:  Mayo Clin Proc       Date:  1996-02       Impact factor: 7.616

6.  Epidural injections for the diagnosis and treatment of low-back pain.

Authors:  A H White; R Derby; G Wynne
Journal:  Spine (Phila Pa 1976)       Date:  1980 Jan-Feb       Impact factor: 3.468

7.  MR imaging of lumbar arachnoiditis.

Authors:  J S Ross; T J Masaryk; M T Modic; R Delamater; H Bohlman; G Wilbur; B Kaufman
Journal:  AJR Am J Roentgenol       Date:  1987-11       Impact factor: 3.959

Review 8.  Systematic review of caudal epidural injections in the management of chronic low back pain.

Authors:  Ann Conn; Ricardo M Buenaventura; Sukdeb Datta; Salahadin Abdi; Sudhir Diwan
Journal:  Pain Physician       Date:  2009 Jan-Feb       Impact factor: 4.965

  8 in total
  3 in total

Review 1.  The leptomeninges as a critical organ for normal CNS development and function: First patient and public involved systematic review of arachnoiditis (chronic meningitis).

Authors:  Carol S Palackdkharry; Stephanie Wottrich; Erin Dienes; Mohamad Bydon; Michael P Steinmetz; Vincent C Traynelis
Journal:  PLoS One       Date:  2022-09-30       Impact factor: 3.752

2.  Cervical Meningomyelitis After Lumbar Epidural Steroid Injection.

Authors:  Yujin Lee; Joon-Sung Kim; Ji Yeon Kim
Journal:  Ann Rehabil Med       Date:  2015-06-30

3.  Persistent cauda equina syndrome after caudal epidural injection under severe spinal stenosis: a case report.

Authors:  Young Tak Seo; Hyun Ho Kong; Goo Joo Lee; Heui Je Bang
Journal:  J Pain Res       Date:  2017-06-12       Impact factor: 3.133

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.